Association between the Thr325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 4, 2008, Pages 494-495

  Verdú, José ^a   Marco, Pascual ^a   Benlloch, Susana ^a   Lucas, Javier ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ISOLEUCINE; THREONINE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

CARDIOVASCULAR RISK; CHI SQUARE TEST; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VENOUS THROMBOEMBOLISM;

CARBOXYPEPTIDASE U; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 51849166149     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607309185     Document Type: Letter

References (5)

1. Schatteman K., Goossens F., Leurs J., et al. Carboxypeptidase U at the interface between coagulation and fibrinolysis. Clin Appl Thromb Hemost 2001 ; 7: 93-101.
2. Eichinger S., Schonauer V., Weltermann A., et al. Thrombin activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. Blood 2004 ; 103: 3773-3776.
3. Zee RY, Hegener HH, Ridker PM Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolism. J Thromb Haemost 2005 ; 12: 2819-2821.
4. Martini CH, Brandts A., de Bruijne EL, et al. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis. Br J Haematol 2006 ; 134: 92-94.
5. Verdu J., Marco P., Benlloch S., Sanchez J., Lucas J. Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD). Thromb Haemost 2006 ; 95: 585-586.